Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model
about
PTPN14 interacts with and negatively regulates the oncogenic function of YAPCXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and BeyondMouse models of pancreatic cancerK-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways.Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens.BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions.PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic functionTargeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.A novel animal model for in vivo study of liver cancer metastasis.YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.Molecular markers associated with outcome and metastasis in human pancreatic cancer.Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells.Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancerAmplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group.Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4.Prognostic signature for pancreatic cancer: are we close?Chemokines in tumor-associated angiogenesis.Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancerReverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer.Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche.Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal AdenocarcinomaAdipose tissue-derived stem cells promote pancreatic cancer cell proliferation and invasion.Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression.Evaluation of the Metabolic Response to Cyclopamine Therapy in Pancreatic Cancer Xenografts Using a Clinical PET-CT SystemThe angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization.Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway.Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment.S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells.The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
P2860
Q24316475-BAE1CC51-AF83-4599-A808-72041ABED238Q24318416-167F15AD-2BFA-4720-95A4-12FC0E984F04Q26744806-306E996B-EEF5-430E-8F51-93638412681AQ26860574-FB4EBAB9-8072-43F9-8227-85E84DC7A19CQ30608512-1F3065FE-26A9-47B6-8109-20FB0DAB2A55Q33372604-B4B8BA8D-B11F-4562-914D-842ED36CB401Q34078104-821B8E85-CDB5-41CB-AB89-0C6BE355C021Q34141098-25FB60A3-98E1-4742-83A6-C0BD58C74E9DQ35161476-A0B3602B-55F1-4E33-B410-6CA61CD802B5Q36144512-3E575709-497D-431E-A8E6-B2D8BC3BD14CQ36237330-F4C73C79-6B5B-486A-83F6-8E9499708C44Q36438761-5B075979-5DEA-4A6D-8CDC-BD3D309129D5Q36551143-1D42337F-3047-427A-9C10-52888C6A6A00Q36787663-4634618B-BEBB-42DF-B5DE-AE7B9C1E2978Q37197386-A47B7902-0EFF-4638-8410-21273659C3F9Q37322616-8B56DA4F-5BD4-4FA5-8438-2E698C9490DFQ37340332-15A1E303-91C8-4590-9AC7-BF2596E58A00Q37448935-0051C8EB-1684-4CD8-91BC-30C8DFEDC486Q37608615-0A0C9C04-62FC-4BEF-BFDA-AB235A11E63EQ37712773-EEC11306-0F82-41E1-A742-C2ECD65385E3Q37716918-85D78605-60AD-419C-BD2D-A5D3595D65DAQ38668174-3445C641-38F6-4C17-962B-EE1D8D03C22EQ38765519-4C6494E8-A78E-4680-8503-B78A3081831BQ39091759-0441EE3A-460D-41DB-8986-164F6062DA4BQ39101616-8E3CA5BF-E2A6-4942-8FAA-5D4082DDE53FQ39474556-F7F4F750-AFE7-44BE-8BBE-F89F702372C3Q41763471-3D31AE8D-A708-4E4F-9F40-C371B4C23865Q44014053-F64C7FE3-BFC2-41F2-A966-20D2A20C182DQ47111118-A43F8176-D0CB-4FD1-B3C1-C3B3A03679CCQ52844421-977EE703-8010-4DCA-A62B-E81CA33F2425Q54290587-FB8025FB-4658-430C-90BC-AADFA4FBDAC7Q54365633-C38C8107-619D-47A7-8A65-C9F4E9933EEB
P2860
Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Gene expression profiling of l ...... an orthotopic SCID mouse model
@ast
Gene expression profiling of l ...... an orthotopic SCID mouse model
@en
type
label
Gene expression profiling of l ...... an orthotopic SCID mouse model
@ast
Gene expression profiling of l ...... an orthotopic SCID mouse model
@en
prefLabel
Gene expression profiling of l ...... an orthotopic SCID mouse model
@ast
Gene expression profiling of l ...... an orthotopic SCID mouse model
@en
P2093
P2860
P356
P1476
Gene expression profiling of l ...... an orthotopic SCID mouse model
@en
P2093
B Heidrich
C Pilarsky
H Allgayer
M Niedergethmann
R Grützmann
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604031
P407
P577
2007-10-16T00:00:00Z
P5875
P6179
1006402403